Profile
Edmund V.
Mickunas is the founder of Seeing Medicines, Inc. He is currently the Chief Regulatory Officer at Neurotech Pharmaceuticals, Inc. in the United States.
Previously, he held senior positions in regulatory affairs and compliance at Control Delivery Systems, Inc., Beacon Therapeutics (USA), Inc., Oragenics, Inc., and Astellas Institute for Regenerative Medicine.
Mr. Mickunas received his graduate degree from Fairfield University and his undergraduate degree from Fairleigh Dickinson University.
Edmund V. Mickunas active positions
| Companies | Position | Start |
|---|---|---|
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | General Counsel | - |
Former positions of Edmund V. Mickunas
| Companies | Position | End |
|---|---|---|
Seeing Medicines, Inc.
Seeing Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage biotechnology company that develops regenerative medicine treatments to restore and maintain vision in people | Founder | - |
Control Delivery Systems, Inc.
Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures drug delivery products | General Counsel | - |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | General Counsel | - |
| OCATA THERAPEUTICS INC | General Counsel | - |
| ORAGENICS, INC. | General Counsel | - |
Training of Edmund V. Mickunas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Control Delivery Systems, Inc.
Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures drug delivery products | Health Technology |
Oragenics, Inc.
Oragenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics and treatments against infectious disease and oral mucositis | Health Technology |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Health Technology |
Fairfield University
Fairfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beacon Therapeutics (USA), Inc.
Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
Astellas Institute for Regenerative Medicine
Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Seeing Medicines, Inc.
Seeing Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage biotechnology company that develops regenerative medicine treatments to restore and maintain vision in people | Commercial Services |
- Stock Market
- Insiders
- Edmund V. Mickunas
















